Inhibition of endothelin-1 and KC1-induced increase of [Ca 2+]i by antiglaucoma drugs in cultured A7r5 vascular smooth-muscle cells

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 3, 2004, Pages 201-209

  Wu, Kwou Yeung ^a   Wang, Hwei Zu ^a   Hong, Show Jen ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; BENZALKONIUM CHLORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; BUNOLGAN; CALCIUM CHANNEL L TYPE; CALCIUM ION; CARTEOLOL; DIPIVEFRINE; DORZOLAMIDE; ENDOTHELIN 1; FURA 2 ACETOXYMETHYL ESTER; LATANOPROST; LEVOBUNOLOL; NIFEDIPINE; PILOCARPINE; POTASSIUM CHLORIDE; SPERSACARPINE; TIMOLOL; TIMOLOL MALEATE; UNCLASSIFIED DRUG; UNOPROSTONE ISOPROPYL ESTER;

ANIMAL CELL; AORTA MEDIA; AREA UNDER THE CURVE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONTROLLED STUDY; DRUG MECHANISM; GLAUCOMA; NONHUMAN; OPTIC NERVE DISEASE; RAT; SPECTROFLUOROMETRY; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; CALCIUM; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; GLAUCOMA; MUSCLE, SMOOTH, VASCULAR; OPHTHALMIC SOLUTIONS; POTASSIUM CHLORIDE; RATS;

EID: 3042727216     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/1080768041223675     Document Type: Article

References (32)

1. Coleman, A.L. Glaucoma. Lancet 354:1803-1810, 1999.
2. Yamazaki, Y., and Drance, S. The relationship between progression of visual field defects and retrobulbar circulation in patients with glaucoma. Am. J. Ophthalmol. 124:287-295, 1999.
3. Harris, A., Sergott, R.C., Spaeth, G.L., Katz, J. L., Shoemaker, J.A., and Martin, B.J. Color Doppler analysis of ocular vessel blood velocity in normal-tension glaucoma. Am. J. Ophthalmol. 118:642-649, 1994.
4. Highsmith, R.F., Pang, D.C., and Rapoport, R.M. Endothelial cell-derived vasoconstrictors: Mechanisms of action in vascular smooth muscle. J. Cardiovasc. Pharmacol. 13:36-44, 1989.
5. Murakawa, K., Kohno, M., Yokokawa, K., Yasunari, K., Horio, T., Kurihara, N., and Takeda, T. Endothelin-induced renal vasoconstriction and increase in cytosolic calcium in renal vascular smooth muscle cell. Clin. Exp. Hypertens. 12:1037-1048, 1990.
6. 2+ mobility in A7r5 cultured vascular smooth muscle cells. Kaohsiung J. Med. Sci. 18:435-442, 2002.
7. Polak, K., Luksch, A., Frank, B., Jandrasits, K., Polska, E., and Schmetterer, L. Regulation of human retinal blood flow by endothelin-1. Exp. Eye Res. 76:633-640, 2003.
8. Ciulla, T.A., Pawlyk, B.S., Harris, A., Oberoi, A., Miller, J.W., and Sandberg, M.A. Endothelin-1-mediated retinal artery vasospasm and the rabbit electroretinogram. J. Ocul. Pharmacol. Ther. 16:393-398, 2000.
9. 2+ mobility in cultured H9c2 myocardiac ventricular cells. Cell Signal. 14:811-817, 2002.
10. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450, 1985.
11. Marsden, P.A., Danthuluri, N.R., Brenner, B.M., Ballermann, B.J., and Brock, T.A. Endothelin action on vascular smooth muscle involves inositol triphosphate and calcium mobilization. Biochem. Biophys. Res. Commun. 158:86-93, 1989.
12. James, C.B., and Smith, S.E. Pulsatile ocular blood flow in patients with low-tension glaucoma. Br. J. Ophthalmol. 75:466-470, 1991.
13. Critini, G. Common pathological basis for the nervous ocular symptoms in chronic glaucoma. Br. J. Ophthalmol. 35:11-20, 1950.
14. Francois, J., and Neetens, A. Vascularity of the eye and the optic nerve in glaucoma. Arch. Ophthalmol. 71:219-225, 1964.
15. Kasuya, Y., Takuwa, Y., Yanagisawa, M., Kimura, S., Goto, K., and Masaki, T. Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover. Biochem. Biophys. Res. Commun. 161:1049-1055, 1989.
16. Chakravarthy, U., and Archer, D.B. Endothelin: A new vasoactive ocular peptide. Br. J. Ophthalmol. 76:107-108, 1992.
17. Tezel, G., Kass, M.A., Kolker, A.E., Becker, B., and Wax, M.B. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J. Glaucoma 16:83-89, 1997.
18. Kallberg, M.E., Brooks, D.E., Garcia-Sanchez, G.A., Komaromy, A.M., Szabo, N.J., and Tian, L. Endothelin 1 levels in the aqueous humor of dogs with glaucoma. J. Glaucoma 11:105-109, 2002.
19. 2+ channels. Eur. J. Pharmacol. 378:317-322, 1999.
20. Sharif, N.A., Xu, S.X., Crider, J.Y., McLaughlin, M., and Davis, T.L. Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: Preclinical pharmacology, IOP-lowering activity and sites of action in human eyes. J. Ocul. Pharmacol. Ther. 17:305-317, 2001.
21. Melena, J., Stanton, D., and Osborne, N.N. Comparative effects of antiglaucoma drugs on voltage-dependent calcium channels. Graefes Arch. Clin. Exp. Ophthalmol. 239:522-530, 2001.
22. Hayashi-Morimoto, R., Yoshitomi, T., Ishikawa, H., Hayashi, E., and Sato, Y. Effects of beta antagonists on mechanical properties in rabbit ciliary artey. Graefes Arch. Clin. Exp. Ophthalmol. 237:661-667, 1999.
23. Hester, R.K., Chen, Z., Becker, E.J., McLaughlin, M., and DeSantis, L. The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery. Surv. Ophthalmol. 38:125-134, 1994.
24. Setoguchi, M., Ohya, Y., Abe, I., and Fujishima, M. Inhibitory action of betaxolol, a beta 1-selective adrenoceptor antagonist, on voltage-dependent calcium channel in guinea-pig artery and vein. Br. J. Pharmacol. 115:198-202, 1995.
25. Ogasawara, H., Yoshida, A., Fujio, N., Konno, S., and Ishiko, S. Effect of topical levobunolol on retinal, optic nerve head, and choroidal circulation in normal volunteers. Nippon. Ganka. Gakkai. Zasshi. 103:544-550, 1999.
26. Altan-Yaycioglu, R., Turker, G., Akdol, S., Acunas, G., and Izgi, B. The effects of beta-blockers on ocular blood flow in patients with primary open angle glaucoma: A color Doppler imaging study. Eur. J. Ophthalmol. 11:37-46, 2001.
27. Flury, H., Tournoux, A., and Martenet, A.C. Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops. Klin. Monatsbl. Augenheilkd. 188:573-575, 1986.
28. ++. Klin. Monatsbl. Augenheilkd. 219:268-272, 2002.
29. Sharif, N.A., Kelly, C.R., and Crider, J.Y. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor. J. Ocul. Pharmacol. Ther. 18:313-324, 2002.
30. Thieme, H., Stumpff, F., Ottlecz, A., Percicot, C.L., Lambrou, G.N., and Wiederholt, M. Mechanisms of action of unoprostone on trabecular meshwork contractility. Invest. Ophthalmol. Vis. Sci. 42:3193-201, 2001.
31. Hayashi, E., Yoshitomi,T., Ishikawa, H., Hayashi, R., and Shimizu, K. Effects of isopropyl unoprostone on rabbit ciliary artery. Jpn. J. Ophthalmol. 44:214-220, 2000.
32. Buckley, C., Hadoke, P.W., Henry, E., and O'Brien, C. Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br. J. Ophthalmol. 86:227-232, 2002.